Details for New Drug Application (NDA): 211173
✉ Email this page to a colleague
The generic ingredient in MYCOPHENOLIC SODIUM is mycophenolic sodium. There are seventeen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the mycophenolic sodium profile page.
Summary for 211173
Tradename: | MYCOPHENOLIC SODIUM |
Applicant: | Concord Biotech Ltd |
Ingredient: | mycophenolic sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 211173
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MYCOPHENOLIC SODIUM | mycophenolic sodium | TABLET, DELAYED RELEASE;ORAL | 211173 | ANDA | CONCORD BIOTECH LIMITED | 68254-5001 | 68254-5001-1 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (68254-5001-1) |
MYCOPHENOLIC SODIUM | mycophenolic sodium | TABLET, DELAYED RELEASE;ORAL | 211173 | ANDA | CONCORD BIOTECH LIMITED | 68254-5001 | 68254-5001-2 | 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (68254-5001-2) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 180MG BASE | ||||
Approval Date: | Dec 13, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 360MG BASE | ||||
Approval Date: | Dec 13, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription